Revista Clínica Española (English Edition)

ISSN: 2254-8874

Revista Clínica Española published its first issue in 1940 and is the body of expression of the Spanish Society of Internal Medicine (SEMI).
The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice. Revista Clínica Española is subject to a thorough double blind review of the received articles written in Spanish or English. Ten issues are published each year, including mostly originals, reviews and consensus documents.

Indexed in:

Current Contents / Clinical Medicine , JCR / SCI-Expanded, Index Medicus / Medline y Excerpta Medica / EMBASE

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.3

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

0.7

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.162

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.211

View more metrics

Open Access Option

Journal Information

Most often read

10795

Doping and sports endocrinology: anabolic-androgenic steroids

J.A. García-Arnés, N. García-Casares

Rev Clin Esp. 2022;222:612-20

10795

Open access

Open Article

6578

Pulmonary embolism during SARS-CoV-2 pandemic: Clinical and radiological features

A. García-Lledó, M. del Palacio-Salgado, C. Álvarez-Sanz, M.M. Pérez-Gil, Á. Cruz-Díaz

Rev Clin Esp. 2022;222:354-8

6578

6367

Systemic capillary leak syndrome after SARS-CoV-2 infection and after COVID-19 vaccination: A scoping review in relation to a clinical case

M. Buj, G. Morales-Varas, A. Pedrosa-Guerrero, E. Alonso-Ciria

Rev Clin Esp. 2022;222:374-6

6367

5264

Clinical characteristics and risk factors for mortality on admission in patients with heart failure hospitalized due to COVID-19 in Spain

P. Llàcer Iborra, J. Núñez Villota

Rev Clin Esp. 2022;222:299-300

5264

5263

Persistent COVID-19 syndrome. A narrative review

A. López-Sampalo, M.R. Bernal-López, R. Gómez-Huelgas

Rev Clin Esp. 2022;222:241-50

5263

4731

Possible effect of the “original antigenic sin” in vaccination against new variants of SARS-CoV-2

J. Reina

Rev Clin Esp. 2022;222:91-2

4731

4144

Real-life effect on the control of risk factors associated with initiation of the cardiovascular polypill created from equipotent drugs

M. Portela-Romero, S. Cinza-Sanjurjo, P. Conde-Sabarís, M. Rodríguez-Mañero, P. Mazón-Ramos, D. Rey-Aldana, J.R. González-Juanateyc

Rev Clin Esp. 2022;222:131-7

4144

Open access

Open Article

4130

Recommendations for oral treatment for adult patients with type 1 Gaucher disease

M.Á. Torralba-Cabeza, M. Morado-Arias, A. Pijierro-Amador, M.C. Fernández-Canal, J. Villarrubia-Espinosa

Rev Clin Esp. 2022;222:529-42

4130

Open access

Open Article

4124

Prognosis of acute heart failure based on clinical data of congestion

B. Espinosa, P. Llorens, V. Gil, X. Rossello, J. Jacob, P. Herrero, F.J. Martín-Sánchez, A. Alquézar-Arbé, ... on behalf of the ICA-SEMES group

Rev Clin Esp. 2022;222:321-31

4124

Open access

Open Article

4094

Vericiguat in heart failure: From scientific evidence to clinical practice

J.R. González-Juanatey, M. Anguita-Sánchez, A. Bayes-Genís, J. Comín-Colet, A. García-Quintana, A. Recio-Mayoral, J.L. Zamorano-Gómez, J.M. Cepeda-Rodrigo, L. Manzano

Rev Clin Esp. 2022;222:359-69

4094

Open access

Open Article

3632

A population-based survey of the prevalence and risk factors of chronic obstructive pulmonary disease in Shanxi Province, China

R. Wang, J. Xu, Y. Wang

Rev Clin Esp. 2022;222:218-28

3632

Open access

Open Article

3493

Comprehensive management of risk factors in peripheral vascular disease. Expert consensus

V. Barrios, P. Beato, C. Brotons, R. Campuzano, J.F. Merino-Torres, J.M. Mostaza, N. Plana, J.A. Rubio, ... CREVASP working group

Rev Clin Esp. 2022;222:82-90

3493

Open access

Open Article

3429

Prevalence and clinical characteristics of symptomatic diffuse interstitial lung disease in rheumatoid arthritis in a Spanish population

M.G. Bonilla Hernán, L. Gómez-Carrera, M. Fernández-Velilla Peña, R. Álvarez-Sala Walther, A. Balsa

Rev Clin Esp. 2022;222:281-7

3429

Open access

Open Article

3397

Consensus on the management of hyperkalemia in patients with heart failure: Recommendations from the SEC-SEMI

L. Almenar Bonet, Á. González-Franco

Rev Clin Esp. 2022;222:235-40

3397

Open access

Open Article

3262

Executive summary clinical practice guideline of postmenopausal, glucocortcioid-induced and male osteoporosis (2022 update). Spanish Society for Bone and Mineral Metabolism Investigation (SEIOMM)

J.A. Riancho, P. Peris, J. González-Macías, J.L. Pérez-Castrillón

Rev Clin Esp. 2022;222:432-9

3262

Open access

Open Article

2739

Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain

A. Salinas-Botrán, J. Sanz-Cánovas, J. Pérez-Somarriba, L.M. Pérez-Belmonte, L. Cobos-Palacios, M. Rubio-Rivas, S. de-Cossío-Tejido, J.M. Ramos-Rincón, ... on behalf of the SEMI-COVID-19 group

Rev Clin Esp. 2022;222:255-65

2739

2602

Executive summary on the treatment of type 2 diabetes mellitus in elderly or frail individuals. 2022 update of the 2018 consensus document “Treatment of type 2 diabetes mellitus in the elderly”

F. Gómez-Peralta, F.J. Carrasco-Sánchez, A. Pérez, J. Escalada, F. Álvarez-Guisasola, C. Miranda-Fernández-Santos, J.J. Mediavilla-Bravo, R. Gómez-Huelgas

Rev Clin Esp. 2022;222:496-9

2602

Open access

Open Article

1872

CURB-65 as a predictor of 30-day mortality in patients hospitalized with COVID-19 in Ecuador: COVID-EC study

J. Carriel, R. Muñoz-Jaramillo, O. Bolaños-Ladinez, F. Heredia-Villacreses, J. Menéndez-Sanchón, J. Martin-Delgado

Rev Clin Esp. 2022;222:37-41

1872

1792

Bempedoic acid in patients with type 2 diabetes

W. Masson, L. Barbagelata, M. Lobo, J.P. Nogueira

Rev Clin Esp. 2022;222:251-3

1792

1574

Incretin-based therapy for glycemic control of hospitalized patients with type 2 diabetes: a systematic review

A.E. Gracia-Ramos, M.P. Cruz-Domínguez, E.O. Madrigal-Santillán

Rev Clin Esp. 2022;222:180-9

1574

Indexed in:

Follow us:

Subscribe:

Most often read

Subscribe to our newsletter